TRDA Annual Shareholders Equity
$242.36 M
+$29.81 M+14.02%
31 December 2023
Summary:
As of January 23, 2025, TRDA annual stockholders equity is $242.36 million, with the most recent change of +$29.81 million (+14.02%) on December 31, 2023. During the last 3 years, it has risen by +$283.85 million (+684.14%). TRDA annual shareholders equity is now -18.87% below its all-time high of $298.72 million, reached on December 31, 2021.TRDA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRDA Quarterly Shareholders Equity
$422.45 M
-$7.48 M-1.74%
30 September 2024
Summary:
As of January 23, 2025, TRDA quarterly stockholders equity is $422.45 million, with the most recent change of -$7.48 million (-1.74%) on September 30, 2024. Over the past year, it has increased by +$175.78 million (+71.26%). TRDA quarterly shareholders equity is now -1.74% below its all-time high of $429.93 million, reached on June 30, 2024.TRDA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRDA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.0% | +71.3% |
| 3 y3 years | +684.1% | +98.8% |
| 5 y5 years | +1661.8% | +98.8% |
TRDA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.9% | +14.0% | -1.7% | +104.2% |
| 5 y | 5-year | -18.9% | +684.1% | -1.7% | +682.0% |
| alltime | all time | -18.9% | +684.1% | -1.7% | +682.0% |
Entrada Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $422.45 M(-1.7%) |
| June 2024 | - | $429.93 M(+59.6%) |
| Mar 2024 | - | $269.37 M(+11.1%) |
| Dec 2023 | $242.36 M(+14.0%) | $242.36 M(-1.7%) |
| Sept 2023 | - | $246.66 M(+19.2%) |
| June 2023 | - | $206.91 M(-9.9%) |
| Mar 2023 | - | $229.61 M(+8.0%) |
| Dec 2022 | $212.55 M | $212.55 M(-8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $233.22 M(-8.9%) |
| June 2022 | - | $256.04 M(-7.7%) |
| Mar 2022 | - | $277.39 M(-7.1%) |
| Dec 2021 | $298.72 M(-820.0%) | $298.72 M(-511.5%) |
| Sept 2021 | - | -$72.59 M(+23.0%) |
| June 2021 | - | -$59.01 M(+42.2%) |
| Dec 2020 | -$41.49 M(+167.4%) | -$41.49 M |
| Dec 2019 | -$15.52 M | - |
FAQ
- What is Entrada Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Entrada Therapeutics?
- What is Entrada Therapeutics annual shareholders equity year-on-year change?
- What is Entrada Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly shareholders equity year-on-year change?
What is Entrada Therapeutics annual stockholders equity?
The current annual shareholders equity of TRDA is $242.36 M
What is the all time high annual shareholders equity for Entrada Therapeutics?
Entrada Therapeutics all-time high annual stockholders equity is $298.72 M
What is Entrada Therapeutics annual shareholders equity year-on-year change?
Over the past year, TRDA annual stockholders equity has changed by +$29.81 M (+14.02%)
What is Entrada Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of TRDA is $422.45 M
What is the all time high quarterly shareholders equity for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly stockholders equity is $429.93 M
What is Entrada Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, TRDA quarterly stockholders equity has changed by +$175.78 M (+71.26%)